Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma

被引:41
作者
Di Benedetto, M.
Pineau, P.
Nouet, S.
Berhouet, S.
Seitz, I.
Louis, S.
Dejean, A.
Couraud, P. O.
Strosberg, A. D.
Stoppa-Lyonnet, D.
Nahmias, C.
机构
[1] Inst Cochin Genet Mol, Dept Biol Cellulaire, F-75014 Paris, France
[2] INSERM, U567, F-75014 Paris, France
[3] CNRS, UMR 8104, F-75014 Paris, France
[4] Univ Paris 05, Fac Med Rene Descartes, UM 3, F-75014 Paris, France
[5] Inst Pasteur, INSERM, U579, Unite Org Nucl & Oncogenese, F-75724 Paris, France
[6] Inst Curie, Lab Genet Oncol, F-75005 Paris, France
关键词
tumor suppressor gene; hepatocellular carcinoma; chromosome; 8p22; MTUS1; ATIP3; CHROMOSOME; 8P; SHORT ARM; AT2; RECEPTOR; CELL-LINES; CANCER; IDENTIFICATION; METASTASIS; REGIONS; DELETION; PROTEIN;
D O I
10.1016/j.mce.2006.03.014
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
A high frequency of allelic loss affecting chromosome 8p and a minimal region of deletion at p21-22 have been previously reported in hepatocellular carcinoma (HCC), suggesting that at least one tumor suppressor gene is present in this region. In this study, we assessed whether the angiotensin II AT2 receptor interacting protein (ATIP)/mitochondrial tumor suppressor gene (MTUSI), a gene newly identified at position 8p22, may be a candidate tumor suppressor gene mutated in HCC. We searched for alterations in the 17 coding exons of ATIP/MTUS1 by means of denaturating high-performance liquid chromatography and sequencing, in 51 HCC tumors and 58 cell lines for which loss of heterozygosity status was known. Five major nucleotide substitutions were identified, all located in exons used by the ATIP3 transcript which is the only ATIP transcript variant expressed in liver. These nucleotide variations result in amino-acid substitution or deletion of conserved structural motifs (nuclear localisation signal, polyproline motif, leucine zipper) and also affect exonic splicing enhancer motifs and physiological splice sites, suggesting potential deleterious effects on ATIP3 function and/or expression. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:207 / 215
页数:9
相关论文
共 41 条
[1]  
Adams J, 2005, CANCER RES, V65, P66
[2]   Aurora kinases: shining lights on the therapeutic horizon? [J].
Andrews, PD .
ONCOGENE, 2005, 24 (32) :5005-5015
[3]   Functional endothelin ETB receptors are selectively expressed in human oligodendrogliomas [J].
Anguelova, E ;
Beuvon, F ;
Leonard, N ;
Chaverot, N ;
Varlet, P ;
Couraud, PO ;
Daumas-Duport, C ;
Cazaubon, S .
MOLECULAR BRAIN RESEARCH, 2005, 137 (1-2) :77-88
[4]   Specific association between alcohol intake, high grade of differentiation and 4q34-q35 deletions in hepatocellular carcinomas identified by high resolution allelotyping [J].
Bluteau, O ;
Beaudoin, JC ;
Pasturaud, P ;
Belghiti, J ;
Franco, D ;
Bioulac-Sage, P ;
Laurent-Puig, P ;
Zucman-Rossi, J .
ONCOGENE, 2002, 21 (08) :1225-1232
[5]   Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298
[6]   ESEfinder: a web resource to identify exonic splicing enhancers [J].
Cartegni, L ;
Wang, JH ;
Zhu, ZW ;
Zhang, MQ ;
Krainer, AR .
NUCLEIC ACIDS RESEARCH, 2003, 31 (13) :3568-3571
[7]   Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors [J].
Chaib, H ;
MacDonald, JW ;
Vessella, RL ;
Washburn, JG ;
Quinn, JE ;
Odman, A ;
Rubin, MA ;
Macoska, JA .
GENES CHROMOSOMES & CANCER, 2003, 37 (03) :306-313
[8]  
Charafe-Jauffret E, 2002, INT J ONCOL, V21, P989
[9]   Two novel regions of interstitial deletion on chromosome 8p in colorectal cancer [J].
Chughtai, SA ;
Crundwell, MC ;
Cruickshank, NRJ ;
Affie, E ;
Armstrong, S ;
Knowles, MA ;
Takle, LA ;
Kuo, M ;
Khan, N ;
Phillips, SMA ;
Neoptolemos, JP ;
Morton, DG .
ONCOGENE, 1999, 18 (03) :657-665
[10]   Identification, using cDNA macroarray analysis, of distinct gene expression profiles associated with pathological and virological features of hepatocellular carcinoma [J].
Delpuech, O ;
Trabut, JB ;
Carnot, F ;
Feuillard, J ;
Brechot, C ;
Kremsdorf, D .
ONCOGENE, 2002, 21 (18) :2926-2937